Citigroup Inc Vaneck ETF Tr Vaneck Pharmaceu Transaction History

Citigroup Inc

  • $150 Billion
  • Q1 2024

A detailed history of Citigroup Inc transactions in Vaneck ETF Tr Vaneck Pharmaceu stock. As of the latest transaction made, Citigroup Inc holds 200 shares of PPH stock, worth $18,296. This represents 0.0% of its overall portfolio holdings.

Number of Shares
200
Previous 200 -0.0%
Holding current value
$18,296
Previous $16,000 12.5%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023
SELL
$76.26 - $83.18 $615,189 - $671,013
-8,067 Reduced 97.58%
200 $15,000
Q2 2023

Aug 10, 2023
BUY
$75.02 - $80.55 $388,153 - $416,765
5,174 Added 167.28%
8,267 $651,000
Q1 2023

May 11, 2023
BUY
$73.68 - $79.63 $131,518 - $142,139
1,785 Added 136.47%
3,093 $240,000
Q4 2022

Feb 09, 2023
BUY
$71.66 - $79.26 $79,399 - $87,820
1,108 Added 554.0%
1,308 $101,000
Q3 2022

Nov 10, 2022
SELL
N/A
-183 Reduced 47.78%
200 $13,000
Q2 2022

Aug 10, 2022
BUY
N/A
183 Added 91.5%
383 $29,000
Q4 2021

Feb 10, 2022
SELL
N/A
-100 Reduced 33.33%
200 $15,000
Q3 2021

Nov 10, 2021
BUY
N/A
300 New
300 $22,000

Others Institutions Holding PPH

# of Institutions
139
Shares Held
4.66M
Call Options Held
18K
Put Options Held
5.5K
View Full List

About VANECK ETF TR VANECK PHARMACEU

PPH Quotes by TradingView
  • Ticker PPH
  • Sector ETFs
  • Industry ETFs
More about PPH
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email